Following promising clinical results, retatrutide, a novel peptide option for treating adult-onset diabetes , has obtained conditional approval from Great Britain's Drug and Healthcare Agency ( MHRA https://nellmegp673113.howeweb.com/41892497/retatrutide-medication-peptide-uk-authorization-and-availability